Home > NRC Library > ADAMS Public Documents

Amend 7 to License 22-16671-01 for Children's Hosp, Biomedical Research Ctr,amending license in entirety.

Accession Number: ML20212R681

Date Released: Tuesday, October 29, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20213A016 - Forwards Amend 7 to License 22-16671-01.Condition 14 added to address bioassays for tritium.Under certain conditions such as using compound HTO,guide recommends bioassays when handling 10% of 0.01 Ci/kg amount listed in Table 1. (1 page(s), 12/2/1986)
• ML20213A043 - Responds to 861010 request for addl info.Users in lab will not be working w/levels in excess of 10 mCi tritium,so bioassays unnecessary.Mandatory radiation survey & wipe test procedures will be done following use of P-32. (2 page(s), 10/28/1986)
• ML20213A049 - Requests addl info re 860127 application for renewal of License 22-16671-01,including verification that 10% of activity levels of tritium will not be exceeded. (2 page(s), 10/10/1986)
• ML20213A055 - Ack receipt of application for renewal of License 22-16671-01. (1 page(s), 3/3/1986)
• ML20213A068 - Forwards application for renewal of License 22-16671-01, changing facility name from Sutton Research Lab to Biomedical Research Ctr.Fee paid. (1 page(s), 1/27/1986)
• ML20213A079 - Application for renewal of License 22-16671-01,authorizing use of 100 mCi H-3,20 mCi C-14 & P-32 & 25 mCi I-125,Cr-51 & S-35 in in vitro lab studies.Fee paid. (13 page(s), 1/27/1986)